Research and Training Funding

Funding Opportunity Announcements

Browse below for Data Science Funding Opportunity Announcements.

This page last reviewed on June 30, 2021

Feed last updated: July 08 2021 8:24 am
Title FOA/Notice Number Issuing Organization Release Date Expiration Date Activity Code
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required) PAR-21-130 NIMH Mar 02 2021 Feb 16 2024 R01
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional) PAR-21-058 NINDS Nov 19 2020 Sep 08 2023 U01
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) PAR-21-059 NINDS Nov 19 2020 Sep 08 2023 U44
Cognitive Systems Analysis of Alzheimer's Disease Genetic and Phenotypic Data (U01 Clinical Trial Not Allowed) PAR-19-269 NIA May 06 2019 Sep 08 2022 U01
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Developmental Project (UH2 Clinical Trial Optional) RFA-AA-21-014 NIAAA Jun 02 2021 Aug 17 2021 UH2
Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Research Project (U01 Clinical Trial optional) RFA-AA-21-010 NIAAA Jun 02 2021 Aug 17 2021 U01
Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional) PAR-20-103 NIGMS Jan 29 2020 Jan 28 2023 RM1
Collaborative Research in Computational Neuroscience (CRCNS) Innovative Approaches to Science and Engineering Research on Brain Function NOT-MH-18-054 NIMH Oct 09 2018 N/A N/A
Collaborative Research in Computational Neuroscience (CRCNS) NSF Innovative Approaches to Science and Engineering Research on Brain Function NOT-MH-20-110 NIMH Sep 30 2020 N/A N/A
Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed) PA-19-033 NIDCR Oct 24 2018 Sep 06 2021 R41/R42
Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed) PA-19-034 NIDCR Oct 24 2018 Sep 06 2021 R43/R44
Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed) PAR-19-171 NINDS Jan 28 2019 Jan 08 2022 UG3/UH3
Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) PAR-19-374 NIA Sep 13 2019 Sep 26 2022 U19
Comprehensive Alcohol Research Centers (P60 Clinical trial Optional) RFA-AA-21-006 NIAAA Apr 05 2021 Nov 16 2021 P60
Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional) PA-21-232 NIMHD May 26 2021 Sep 08 2024 R01
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed) PAR-20-304 NLM Sep 15 2020 May 08 2023 R01
Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) PAR-21-132 NIMH Mar 02 2021 Feb 16 2024 R01
Consortium for Innovative HIV/AIDS Vaccine and Cure Research (UM1 Clinical Trial Not Allowed) RFA-AI-21-039 NIAID May 07 2021 Aug 05 2021 UM1
Contraceptive Development Research Centers Program (P50 Clinical Trial Optional) RFA-HD-22-003 NICHD Nov 19 2020 Nov 30 2021 P50
Coordinating Center for Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U24 Clinical Trial Not Allowed) RFA-CA-21-032 NCI May 03 2021 Jul 15 2021 U24
Coordinating Center for the Metabolic Dysregulation and Cancer Risk Program: A Transdisciplinary Approach to Obesity-Associated Cancer Research (U24 Clinical Trial Not Allowed) RFA-CA-21-022 NCI Jul 06 2021 Oct 07 2021 U24
Coordinating Center for the Program on the Origins of Gastroesophageal Cancers (U24 Clinical Trial Not Allowed) RFA-CA-21-027 NCI Jun 25 2021 Oct 09 2021 U24
Core Centers for Clinical Research (CCCR) (P30)- Clinical Trial Not Allowed RFA-AR-22-002 NIAMS Mar 19 2021 Sep 14 2021 P30
Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional) PAR-20-316 NINDS Dec 21 2020 Sep 13 2023 U54
Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional) PAR-19-040 NINDS Oct 26 2018 Sep 15 2021 U01

Pages

XLS